Behavioral program to improve quality of life and prevent heart and metabolic problems in people with HIV
Theoretically Informed Behavioral Intervention to Enhance QOL and Prevent HIV-related Comorbidities
This project offers a behavior-focused program to help people living with HIV improve lifestyle habits to lower their chances of heart disease, high blood pressure, and diabetes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11382009 on NIH RePORTER |
What this research studies
If you join, you would get a structured behavioral program aimed at improving diet, physical activity, sleep, and tobacco use to reduce common health problems that occur with HIV. The program is informed by behavioral theory and tailored to address the social and environmental factors that raise risk, especially among Black and Hispanic men. It will track health markers linked to cardiovascular and metabolic risk and provide support to help you make sustainable changes. The goal is to improve day-to-day quality of life while lowering long-term risk for heart disease, high blood pressure, and diabetes.
Who could benefit from this research
Good fit: Adults living with HIV—particularly Black and Hispanic men, older adults, or those with elevated blood pressure, high cholesterol, obesity, or high blood sugar—are ideal candidates.
Not a fit: People without HIV or those with advanced, irreversible cardiovascular disease who need immediate medical procedures may not gain direct benefit from this behavioral program.
Why it matters
Potential benefit: If successful, this could help people with HIV lower their risk of heart disease and diabetes and improve overall quality of life.
How similar studies have performed: Related lifestyle and behavioral programs have helped reduce risk factors in general and some HIV populations, but long-term impact on heart events in people with HIV is still being established.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Ramos, Silvia Raquel — Yale University
- Study coordinator: Ramos, Silvia Raquel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.